Follow
Kasireddy Sudarshan
Kasireddy Sudarshan
Associate Research Scientist, Purdue University
Verified email at purdue.edu - Homepage
Title
Cited by
Cited by
Year
Inhibition of the enzymes in the leukotriene and prostaglandin pathways in inflammation by 3-aryl isocoumarins
M Ramanan, S Sinha, K Sudarshan, IS Aidhen, M Doble
European Journal of Medicinal Chemistry 124, 428-434, 2016
222016
Regulation of mRNA translation by a photoriboswitch
KA Rotstan, MM Abdelsayed, LFM Passalacqua, F Chizzolini, ...
Elife 9, e51737, 2020
212020
A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy
AM Abdelaal, IS Sohal, S Iyer, K Sudarshan, H Kothandaraman, ...
Oncogene 42 (40), 2985-2999, 2023
122023
Development of a simple high-throughput assay for directed evolution of enantioselective sulfoxide reductases
V Tarallo, K Sudarshan, V Nosek, J Míšek
Chemical communications 56 (40), 5386-5388, 2020
112020
Discovery of an isocoumarin analogue that modulates neuronal functions via neurotrophin receptor TrkB
K Sudarshan, A kumar Boda, S Dogra, I Bose, PN Yadav, IS Aidhen
Bioorganic & Medicinal Chemistry Letters 29 (4), 585-590, 2019
112019
Convenient Synthesis of 3‐Glycosylated Isocoumarins
K Sudarshan, IS Aidhen
European Journal of Organic Chemistry 2017 (1), 34-38, 2017
102017
Synthesis of (+)‐Centrolobine and Its Analogues by Using Acyl Anion Chemistry
K Sudarshan, IS Aidhen
European Journal of Organic Chemistry 2013 (12), 2298-2302, 2013
102013
Synthesis of 3‐Arylisocoumarins by Using Acyl Anion Chemistry and Synthesis of Thunberginol A and Cajanolactone A
K Sudarshan, MK Manna, IS Aidhen
European Journal of Organic Chemistry 2015 (8), 1797-1803, 2015
82015
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises
W Li, Y Wang, X Liu, S Wu, M Wang, SG Turowski, JA Spernyak, A Tracz, ...
International Journal of Molecular Sciences 25 (4), 2123, 2024
12024
Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent
AM Abdelaal, IS Sohal, SG Iyer, K Sudarshan, EA Orellana, KE Ozcan, ...
Molecular Therapy-Nucleic Acids, 102193, 2024
2024
Further development of microRNA-34a therapeutics to target castration-resistant prostate cancer
W Li, X Liu, AM Abdelaal, S Kasireddy, Y Su, Y Wu, AL Kasinski, DG Tang
Cancer Research 83 (7_Supplement), 2716-2716, 2023
2023
Dual targeting of tumor cells and cancer associated fibroblasts enhances CAR T efficacy in solid tumors
B Huang, S Zheng, H Chu, R Mukkamala, SK Bowroju, Y Singh, ...
Cancer Research 83 (7_Supplement), 4099-4099, 2023
2023
Design of bispecific adapters for universal CAR T cell therapies of solid tumors
S Zheng, B Huang, Y Singh, H Chu, SK Bowroju, MS Bari, M Srinivasarao, ...
Cancer Research 83 (7_Supplement), 1787-1787, 2023
2023
Targeting cancer cells using folate conjugated to a fully modified version of miR-34a (FolamiR-34a) to produce enhanced and sustained anti-tumor activity
SG Iyer, AM Abdelaal, IS Sohal, SR Kasireddy, AL Kasinski
Cancer Research 83 (7_Supplement), 3782-3782, 2023
2023
Efficient targeting of prostate cancer using ligand conjugated and chemically modified tumor suppressive miRNA
AM Abdelaal, S Kasireddy, IS Sohal, PS Low, AL Kasinski
American Association for Cancer Research 82 (12), 1482, 2022
2022
5-methyltetrahydrofolate (5-MTHF) as a superior ligand for delivery of small RNAs for cancer therapy
SR Kasireddy, AM Abdelaal, PS Low, AL Kasinski
American Association for Cancer Research 82 (12), 1494, 2022
2022
Synthesis of Unsymmetrical Linear Diarylheptanoids and their Enantiomers and Antiproliferative Activity Studies
K Sudarshan, G Perumal, IS Aidhen, M Doble
European Journal of Organic Chemistry 2018 (45), 6379-6387, 2018
2018
Convenient access to 3-Aryl Isocoumarins Using Acyl Anion Chemistry and Synthesis of Thunberginol A
K Sudarshan, MK Manna, IS Aidhen
The system can't perform the operation now. Try again later.
Articles 1–18